David Heimbrook

La Roche College

Papers

1

Total Citations

234

H-Index

1

About

David Heimbrook’s research has fundamentally reshaped our understanding of the p53 tumor suppressor pathway. His most influential work, including a landmark 2004 study with 234 citations, challenged the prevailing dogma that specific serine phosphorylations of p53 are essential for its transcriptional activation and pro-apoptotic functions. Through elegant genetic experiments, Heimbrook demonstrated that these post-translational modifications are, in fact, dispensable—a finding that redirected the field toward other regulatory mechanisms. Beyond this pivotal contribution, his broader research has illuminated how stress signals converge on p53, revealing alternative layers of control that govern cell fate decisions. Heimbrook’s work has had a lasting impact on cancer biology, influencing therapeutic strategies aimed at reactivating p53 in tumors. His rigorous, hypothesis-driven approach has earned him recognition as a critical thinker who was unafraid to overturn established models. For students and researchers, Heimbrook’s legacy serves as a powerful reminder that the most important discoveries often come from questioning what everyone else assumes to be true.

Research Focus

Key Achievements

1
H-Index
1
Papers
234
Total Citations
234
Avg Citations/Paper
🏆 Most Cited Paper
Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis
234 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: La Roche College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago